Plant Advanced Technologies SA (ALPAT) AI Stock Analysis

1 Followers

Plant Advanced Technologies SA

(Paris:ALPAT)

Select Model

Rating:70Outperform

Price Target:EUR 9.50▲(138.69% Upside)

Action:upgraded

Date:02/03/26

Solid financial recovery in 2024 drives score, supported by stable technicals; tempered by negative P/E and overbought signals.

Positive Factors

Return to ProfitabilityA return to material profitability and a ~48% net margin in 2024 indicates the business can generate economic profit at current scale. Durable profits improve reinvestment capacity for R&D/commercialization, support creditor confidence, and reduce reliance on dilutive financing if maintained.

Negative Factors

Small, Volatile Revenue BaseA small and volatile revenue base undermines the durability of margins and cash flow; sharp swings (deep declines in prior years and a modest rebound) increase execution risk, limit scale economies, and make multi-quarter forecasting and reinvestment planning more uncertain.

Plant Advanced Technologies SA (ALPAT) vs. iShares MSCI France ETF (EWQ)

Market Cap: EUR 4.53M
Dividend Yield: ―
Average Volume (3M): 271
Price to Earnings (P/E): 6.6
Beta (1Y): 0.22
Revenue Growth: 10.59%
EPS Growth: ―
Country: France
Employees: 11
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Plant Advanced Technologies SA Business Overview & Revenue Model

Company Description

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce you...

How the Company Makes Money

null

Plant Advanced Technologies SA Financial Statement Overview

Summary

Strong 2024 turnaround with revenue up 14.6%, 48.5% net profit margin, improved debt-to-equity at 0.37, positive ROE of 10.2%, and robust €2.50M operating cash flow, offsetting prior losses and volatility.

Income Statement

72Positive

Balance Sheet

78Positive

Cash Flow

82Very Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.14M	1.14M	1.93M	1.68M	2.34M	2.31M
Gross Profit	-693.73K	-693.73K	2.24M	2.15M	-4.65M	-2.73M
EBITDA	205.66K	-693.73K	956.45K	185.78K	-744.00K	-1.27M
Net Income	569.40K	569.40K	935.13K	79.17K	-849.00K	-1.13M
Balance Sheet
Total Assets	16.37M	16.37M	16.00M	14.91M	17.08M	17.11M
Cash, Cash Equivalents and Short-Term Investments	55.00K	55.00K	79.70K	0	669.00K	2.49M
Total Debt	3.74M	3.62M	3.42M	4.36M	5.97M	6.14M
Total Liabilities	6.53M	6.53M	6.83M	6.78M	10.29M	9.73M
Stockholders Equity	9.84M	9.84M	9.17M	8.13M	5.50M	6.36M
Cash Flow
Free Cash Flow	0	0	2.08M	972.53K	-479	-504
Operating Cash Flow	0	0	2.50M	1.85M	-274	-388
Investing Cash Flow	0	0	-1.59M	-1.28M	-1,968	-1,111
Financing Cash Flow	0	0	-585.89K	-851.03K	244	743

Plant Advanced Technologies SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

FR:ALPAT against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:ALPAT	70Outperform	EUR 4.52M	6.59	―	―	10.59%	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
FR:ALTME	46Neutral	EUR 10.28M	-6.30	80.75%	―	―	―
FR:POXEL	46Neutral	EUR 8.22M	-0.39	33.88%	―	―	―
FR:ALBPS	42Neutral	EUR 16.02M	-0.02	153.48%	―	―	90.97%
FR:ALNEV	37Underperform	EUR 140.09K	0.00	-26.52%	―	-9.52%	100.00%

* Healthcare Sector Average

Performance Comparison

FR:ALPAT and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
FR:ALPAT	Plant Advanced Technologies SA	3.98	-4.52	-53.18%
FR:POXEL	Poxel SA	0.15	-0.12	-45.05%
FR:ALTME	TME Pharma N.V.	0.11	0.04	46.75%
FR:ALBPS	Biophytis SA	0.04	-0.04	-53.01%
FR:ALNEV	Neovacs SA	0.08	-268.92	-99.97%

Plant Advanced Technologies SA Corporate Events

Plant Advanced Technologies Enters Court-Supervised Restructuring to Support Recovery Plan

Jul 23, 2026

Plant Advanced Technologies SA has been placed under court-supervised restructuring by the Commercial Court of Nancy after declaring a suspension of payments, with a renewable six-month observation period that freezes its liabilities and secures a le...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Feb 03, 2026

Plant Advanced Technologies SA AI Stock Analysis